History | Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 229 KB)

Published:

23 January 2017

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 380 KB)

Published:

17 November 2016
Committee papers (PDF 1.13 MB)

Published:

17 November 2016

Notes

Note

Invitation to participate

Final matrix (PDF 96 KB)

Published:

19 July 2016
Final scope (PDF 62 KB)

Published:

19 July 2016

Final appraisal determination

Final appraisal determination document TA251 (PDF 735 KB)

Published:

15 March 2012
Committee papers TA251 (PDF 2.71 MB)

Published:

15 March 2012

Draft guidance: TA251

Committee papers (PDF 15.03 MB)

Published:

10 November 2016
Appraisal consultation document TA251 (PDF 669 KB)

Published:

10 November 2016

Invitation to participate

Final scope TA251 (PDF 212 KB)

Published:

04 February 2011
Final matrix TA251 (PDF 66 KB)

Published:

04 February 2011
Draft scope and provisional matrix comments table (post-referral) TA251 Draft scope comments (PDF 387 KB)

Published:

04 February 2011
Draft scope and provisional matrix comments table (post-referral) TA251 Draft matrix comments (PDF 252 KB)

Published:

04 February 2011